BioNTech SE Announces Leadership Transition

In a strategic move to bolster its leadership team, BioNTech SE has announced the appointment of Ramon Zapata-Gomez as its new Chief Financial Officer, effective July 1, 2025. This transition marks the retirement of Jens Holstein, who has served the company with distinction.

Bringing Global Expertise to BioNTech

Currently serving as CFO at Novartis's global biomedical research unit, Zapata-Gomez brings a wealth of experience from his tenure across North America, Europe, and Latin America. His global perspective and financial acumen are expected to play a pivotal role in BioNTech's ongoing mission.

Leadership and Vision for the Future

Helmut Jeggle, Chairman of the Supervisory Board, lauded Zapata-Gomez as "an accomplished leader with deep finance expertise", highlighting his keen understanding of market dynamics and exceptional team leadership. Zapata-Gomez expressed his enthusiasm about joining BioNTech, stating his eagerness to contribute to the company's mission of "improving patients' lives."